GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
February 01 2024 - 4:05PM
Business Wire
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the
“Company”), the leading destination for prescription savings in the
U.S, today announced it will release its fourth quarter and full
year 2023 financial results before U.S. markets open on Thursday,
February 29, 2024. GoodRx management will also hold a conference
call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m.
Eastern Time) to discuss the results and the Company’s business
outlook.
To access the conference call, please pre-register using this
link. Registrants will receive a confirmation with dial-in details
and a unique passcode required to join. The call will also be
webcast live on the Company’s investor relations website at
https://investors.goodrx.com, where accompanying materials will be
posted prior to the conference call.
Approximately one hour after completion of the live call, an
archived version of the webcast will be available on the Company’s
investor relations website at https://investors.goodrx.com for at
least 30 days.
About GoodRx
GoodRx is the leading destination for prescription savings in
the U.S. We offer consumers free access to transparent and lower
prices for generic and brand medications, as well as comprehensive
healthcare research and information. We also equip healthcare
providers with efficient ways to find and prescribe affordable
medications. Since 2011, GoodRx has helped consumers save more than
$65 billion and is one of the most downloaded medical apps over the
past decade.
GoodRx periodically posts information that may be important to
investors on its investor relations website at
https://investors.goodrx.com. We intend to use our website as a
means of disclosing material nonpublic information and for
complying with our disclosure obligations under Regulation FD.
Accordingly, investors and potential investors are encouraged to
consult GoodRx’s website regularly for important information, in
addition to following GoodRx’s press releases, filings with the
Securities and Exchange Commission (the “SEC”) and public
conference calls and webcasts. The information contained on, or
that may be accessed through, GoodRx’s website is not incorporated
by reference into, and is not a part of, this press release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240201197036/en/
Investor Contact GoodRx Whitney Notaro
wnotaro@goodrx.com
Press Contact GoodRx Lauren Casparis
lcasparis@goodrx.com
GoodRx (NASDAQ:GDRX)
Historical Stock Chart
From Apr 2024 to May 2024
GoodRx (NASDAQ:GDRX)
Historical Stock Chart
From May 2023 to May 2024